tuned seed round

Tuned Raises $2.5M Seed Round with Aim to ‘Radically Upend Status Quo’ in Hearing Care

NEW YORK CITY, NEW YORK — Tuned, a hearing health company focused on providing hearing care for all, today announced that it raised $2.5 million in seed funding, led by Idealab NY and Elements Health Ventures. Following successful pilots with companies such as RetailBound and Mishe, the injection of new capital will be used to scale employer adoption and…

Read More
akouos gene therapy hearing loss

Akouos Receives FDA Clearance of its IND Application for Gene Therapy Hearing Loss Treatment, AK-OTOF

BOSTON, MASSACHUSSETTS — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to initiate a Phase 1/2, first in human,…

Read More

NIH Genomics Researchers Identify Unique Set of Proteins that Restore Hearing in Zebrafish

WASHINGTON, D.C. — National Institutes of Health researchers have discovered a specific network of proteins that is necessary to restore hearing in zebrafish through cell regeneration. The study, led by investigators at the National Human Genome Research Institute (NHGRI), may inform the development of treatments for hearing loss in humans. The findings were published in Cell Genomics.…

Read More
cochlear sensorion sens-401

First Patient Enrolled in Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation

MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has announced that the first patient has been enrolled in its proof-of-concept clinical trial of SENS-401 (Arazasetron) in patients scheduled for cochlear implantation.…

Read More
euha logo

2022 EUHA Congress to Take Place on October 12th

FRANKFURT/MAINZ — The 66th International Congress of Hearing Aid Acousticians (EUHA) and the accompanying Industry Exhibition will provide insights into innovations in the field of hearing on October 12, 2022. More than 25 top-class expert lectures, five tutorials, and four forward-looking Future  Friday lectures will be on offer for participants. In addition, they will debut…

Read More

Sony and WS Audiology Announce Partnership on OTC Self-Fitting Hearing Aid Business

TOKYO AND LYNGE, DENMARK — Sony Corporation and WS Audiology Denmark A/S have entered into a partnership agreement and various ancillary agreements with the aim of jointly developing and supplying new products and services in the over-the-counter self-fitting hearing aid market, beginning with the United States. Through the partnership, Sony and WSA will combine their respective technological…

Read More

Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT from the European Medicine Agency

MONTPELLIER, FRANCE – Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage  biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion on Sensorion’s application for Orphan…

Read More

Andrew Bellavia Launches AuraFuturity, A Hearing Health and Hearables Consultancy

Andrew Bellavia has today announced the launch of a new consulting business, AuraFuturity, to serve the hearing health and related hearables markets. Focusing on go-to-market, branding, and content, AuraFuturity is positioned to assist innovators to define their value and communicate it effectively to their target customers.  “Untreated hearing loss is a global pandemic with more…

Read More
oticon own custom hearing aids

More Than 2500 Hearing Professionals Register for Oticon Own Launch Event

SOMERSET, NEW JERSEY — More than 2,500 hearing care professionals registered for the knowledge-sharing Oticon Own™ launch event, including a live audience at Oticon US headquarters in Somerset, NJ who joined alongside virtual participants from across the US. The launch event introduced Oticon Own™, the world’s first custom hearing aid with an on-board Deep Neural…

Read More
otolith labs funding 20 million

Otolith Labs Raises $20M Series A to Develop Wearable Vertigo Treatment Device

WASHINGTON D.C.  — Otolith Labs, a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, announced the closing of a $20 million Series A financing round by Morningside Ventures. Building on prior investments from businessman Mark Cuban and leading ENT physicians, the proceeds will be used to support the company’s…

Read More